Lv1
44 积分 2024-09-01 加入
Angiotensin Receptor–Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction
1天前
已完结
FABP4 Enhances Lipidic and Fibrotic Cardiac Structural and Ca 2+ Dynamic Changes
2个月前
已完结
Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor
3个月前
已完结
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone
4个月前
已完结
Immune checkpoint inhibitors plus anlotinib versus anlotinib alone as third-line treatment in advanced non-small-cell lung cancer: a retrospective study
4个月前
已完结
Incidence of Cardiovascular Events in Patients Treated With Immune Checkpoint Inhibitors
4个月前
已完结
Impact of PD-L1 expression on the efficacy of first-line crizotinib in advanced ROS1-rearranged NSCLC
5个月前
已完结
Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?
5个月前
已完结
FABP4 Enhances Lipidic and Fibrotic Cardiac Structural and Ca 2+ Dynamic Changes
5个月前
已完结
Temporal and Spatial Changes of Proarrhythmic Substrate in Premature Ventricular Contraction–Induced Cardiomyopathy
6个月前
已完结
皖公网安备34019202002308
